Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-112-2 | CAS number: 115-86-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: conforms to current guideline and GLP.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- This Guinea pig maximization test was performed in 2001, i.e. before the LLNA became the standard test for assessment.
- Specific details on test material used for the study:
- - Name of test material (as cited in study report): TPP
- Physical state: White granular solid
- Lot/batch No.: F21022
- Storage condition of test material: room temperature in the dark - Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- male
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: supplied by David Hall Limited UK
- Age at study initiation: 8-12 weeks
- Weight at study initiation: 345 - 410 g
- Housing: singly or in pairs in solid floor polyproylene cages furnished with woodflakes
- Diet (e.g. ad libitum): Free access to guinea pig FD1 diet
- Water (e.g. ad libitum): Free access to tap water
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 17 to 23 deg C
- Humidity (%): 30 to 70%
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12 hours dark/12 hours/light
- Route:
- intradermal
- Vehicle:
- arachis oil
- Concentration / amount:
- intradermal induction: 5%
topical induction: 75 %
topical challenge: 75 % and 50 % - Route:
- epicutaneous, occlusive
- Vehicle:
- arachis oil
- Concentration / amount:
- intradermal induction: 5%
topical induction: 75 %
topical challenge: 75 % and 50 % - No. of animals per dose:
- 10 test and 5 control
- Details on study design:
- 1st application; intradermal induction:
Shortly before treatment the hair was removed from an area approx. 40 x 60 mm on the sholder region of each animal. A row of three injections was made:
a) Freud's Complete Adjuvant plus destilled water in a ration 1:1
b) 5 % w/w TPP in arachis oil
c) a 5% w/w formulation of TPP in a 1:1 preparation with Freud's Complete Adjuvant plus destiled water
Approx. 24 and 48 hours after intradermal induction the degree of erythema at the test material injection site was evaluated.
2nd application; topical induction:
On day 7 the same area was clipped again and treated with topical application of the test material (75 % w/w in arachis oil; occlusive epicutaneous)
3rd application topical Challenge:
On day 21 an area of approx. 50 x 70 mm on both flancs of each animal was ciplled free of hair and topicallytreated with 75 % and 50% w/w TPP in arachis oil (occlusive epicutaneous) - Positive control substance(s):
- yes
- Remarks:
- 2-Mercaptobenothiazole
- Positive control results:
- The positive control gave the expected positive results (see results table)
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- positive control
- Dose level:
- 50% and 25% in acetone:PEG 400 (70:30)
- No. with + reactions:
- 10
- Total no. in group:
- 10
- Clinical observations:
- no data
- Remarks on result:
- positive indication of skin sensitisation
- Remarks:
- summary of 6 tests (9-10 positive reactions/10 animals)
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 50 and 75 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- no data
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 50 and 75 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- no data
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 50 and 75%
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 50 and 75%
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- 50 and 25% 2-Mercaptobenzothiazole
- No. with + reactions:
- 10
- Total no. in group:
- 10
- Remarks on result:
- positive indication of skin sensitisation
- Remarks:
- summary of 6 tests (9-10 positive reactions/10 animals)
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- not sensitizing
- Executive summary:
A study was performed to assess the contact sensitisation potential of TPP in guinea pigs according to OECD guidelines study 406. Ten test and five control animals were used for the study. Two phases were involved in the main study; an induction of a response by intradermal injection and topical application and a topical challenge of that response. Based on sighting tests, the concentrations of TPP for the induction and challenge phases were selected as:
Intradermal induction: 5%w/w in arachis oil; Topical Induction: 75%w/w in arachis oil; Topical challenge 75 and 50%w/w in arachis oil. The results showed that TPP produced a 0% (0/10) sensisitisation rate and classified as a non-sensitiser to guinea pig skin.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
A study was performed to assess the contact sensitisation potential of triphenyl phosphate in guinea pigs according to OECD guideline study 406. Ten test and five control animals were used for the study. Two phases were involved in the main study; an induction of a response by intradermal injection and topical application and a topical challenge of that response. Based on sighting tests, the concentrations of triphenyl phosphate for the induction and challenge phases were selected as:
Intradermal induction: 5%w/w in arachis oil; Topical Induction: 75%w/w in arachis oil; Topical challenge 75 and 50%w/w in arachis oil. The results showed that triphenyl phosphate produced a 0% (0/10) sensisitisation rate and classified as a non-sensitiser to guinea pig skin.
The OECD Guideline 406 (1992) for the Guinea pig maximisation test (GPMT) requires treatment of the test site with SLS prior to topical induction with non-irritating test materials, based on the studies of Magnusson and Kligman (1969). Such a treatment induces an additional provokation of skin inflammation. Later assessments of scientific experts for skin sensitization (see ECETOC Report No. 29 of September 2000, pages 17-18, and Steiling et al., Food and Chemical Toxicology 39, 293-301, 2001) come to the conclusion that SLS should no longer be used as a pretreatment in the GPMT. The rational for this recommendation, besides animal welfare reasons, is given here in short (for further details see attached pages of the ECETOC Report):
• The skin is already inflamed by the use of Freud’s Complete Adjuvant (FCA).
• SLS facilitates percutaneous absorption of the test material in a non-adequate (non-physiologic) manner.
• Skin integrity may be compromised by SLS, resulting in hyperirritable skin.
• SLS may in some circumstances act itself as an allergen.
• Animals that are already aggressively treated by FCA may be traumatized by additional irritation via SLS that may compromise performance of the test.
Following this recommendation all inhouse GPMTs have been performed without SLS treatment since 2001. This deviation from guideline has no impact on the validity of the test and the reliability of the result.
Discussion of human information:
Single human cases have been reported with allergic dermatitis from TPP through the years (Andersen, 1977; Berkhoff, 1938; Carlsen, 1986; Hjorth, 1964; Pegum, 1966; Spritig, 1995).
Among the 23192 patients patch tested from 1950 to 1962, positive reactions to cellulose acetate film containing 7 to 10% triphenyl phosphate and 3 to 4% phthalic esters occured in 15 (0.065%). The sensitivity to ceullose acetate film was analysed in only two cases, in both of which the sensitiser was found to be trihphenyl phosphate. In the others it may have been either triphenyl phosphate or phthalic ester (Hjorth, 1964).
In a retrospective evaluation of human patch tests, none of the 343 patients reacted to TPP (Tarvainen, 1995).
174 patients patch tested with a variety of plastic and glue allergens showed no allergic reaction towards TPP. One patient showed signs of irritation. This indicates TPP did not cause skin sensitisation (Kanerva, 1997). In a retrospective evaluation of human patch tests, 1 of 358 patients reacted positive to TPP at 5% between 1991 -1996. 3 out of 358 patients showed irritation (Kanerva, 1997).
The authors in this review of five references conclude that only scarce indication of contact sensitising potential from TPP (Kayser, 2001).
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Triphenyl phosphate was tested negative in a Guinea pig maximization test (OECD 406). According to EU Regulation 1272/2008 triphenyl phosphate does not meet the requirements for classification as a skin sensitiser.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
